Ertugliflozin in Patients with Stage 3 Chronic Kidney Disease and Type 2 Diabetes Mellitus: The VERTIS RENAL Randomized Study

被引：0
|
作者：
George Grunberger
Sarah Camp
Jeremy Johnson
Susan Huyck
Steven G. Terra
James P. Mancuso
Zhi Wei Jiang
Gregory Golm
Samuel S. Engel
Brett Lauring
机构：
[1] Grunberger Diabetes Institute,
[2] Merck & Co.,undefined
[3] Inc.,undefined
[4] Pfizer Inc.,undefined
[5] Pfizer Inc.,undefined
[6] MSD China,undefined
来源：
Diabetes Therapy | 2018年 / 9卷
关键词：
Chronic kidney disease; Ertugliflozin; Glycemic control; SGLT2 inhibitor; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：49 / 66
页数：17
相关论文
共 50 条
  • [41] Association between triglyceride-glucose index and risk of end-stage renal disease in patients with type 2 diabetes mellitus and chronic kidney disease
    Gao, Yue-Ming
    Chen, Wei-Jia
    Deng, Zhen-Ling
    Shang, Zhi
    Wang, Yue
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [42] Ertugliflozin in Older Patients with Type 2 Diabetes (T2D): An Analysis from VERTIS CV
    Pratley, Richard E.
    Dagogo-Jack, Samuel
    Charbonnel, Bernard
    Cherney, David
    Cosentino, Francesco
    Mcguire, Darren K.
    Essex, Margaret N.
    Jones, Philip L. S.
    Liu, Jie
    Adamsons, Ingrid A.
    Lawrence, David
    Shih, Weichung J.
    Cannon, Christopher P.
    [J]. DIABETES, 2021, 70
  • [43] Safety of Ertugliflozin in Patients with Type 2 Diabetes Mellitus: Pooled Analysis of Seven Phase 3 Randomized Controlled Trials
    Shrita Patel
    Anne Hickman
    Robert Frederich
    Susan Johnson
    Susan Huyck
    James P. Mancuso
    Ira Gantz
    Steven G. Terra
    [J]. Diabetes Therapy, 2020, 11 : 1347 - 1367
  • [44] Predicting Decline of Renal Function among People With Stage 3 Chronic Kidney Disease and Type 2 Diabetes
    Looker, Helen C.
    Deshmukh, Harshal
    Morris, Andrew D.
    Palmer, Colin N.
    Colhoun, Helen M.
    [J]. DIABETES, 2012, 61 : A141 - A141
  • [45] Mediators of ertugliflozin effects on heart failure and kidney outcomes among patients with type 2 diabetes mellitus
    Segar, Matthew W.
    Kolkailah, Ahmed A.
    Frederich, Robert
    Pong, Annpey
    Cannon, Christopher P.
    Cosentino, Francesco
    Dagogo-Jack, Samuel
    McGuire, Darren K.
    Pratley, Richard E.
    Liu, Chih-Chin
    Maldonado, Mario
    Liu, Jie
    Cater, Nilo B.
    Pandey, Ambarish
    Cherney, David Z., I
    [J]. DIABETES OBESITY & METABOLISM, 2022, 24 (09): : 1829 - 1839
  • [46] Treatment Patterns of Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease in Colombia
    Machado, Manuel
    Gaviria-Mendoza, Andres
    Franco, Juan S.
    Forero, Maria D. R.
    Vizcaya, David
    Restrepo, Luis F. Valladales
    Machado-Alba, Jorge E.
    [J]. DIABETES, 2023, 72
  • [47] Optimizing Multidisciplinary Care of Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus
    Kelepouris, Ellie
    St. Peter, Wendy
    Neumiller, Joshua J.
    Wright, Eugene E.
    [J]. DIABETES THERAPY, 2023, 14 (07) : 1111 - 1136
  • [48] CYSTATIN C IN THE DIAGNOSIS OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Yarkova, N. A.
    Borovkov, N. N.
    Zanozina, O. V.
    Nosov, V. P.
    [J]. SOVREMENNYE TEHNOLOGII V MEDICINE, 2013, 5 (04) : 89 - 92
  • [49] Chronic kidney disease in patients with diabetes mellitus type 2 or hypertension in general practice
    van der Meer, Victor
    Wielders, H. Petra M.
    Grootendorst, Diana C.
    de Kanter, Joost S.
    Sijpkens, Yvo W. J.
    Assendelft, Willem J. J.
    Gussekloo, Jacobijn
    Dekker, Friedo W.
    Groeneveld, Ymte
    [J]. BRITISH JOURNAL OF GENERAL PRACTICE, 2010, 60 (581): : 884 - 890
  • [50] Finerenone (Kerendia) for the Treatment of Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus
    Stewart-Lynch, Autumn
    [J]. AMERICAN FAMILY PHYSICIAN, 2023, 108 (03) : 305 - 306
12345